Microbio Co (4128.TWO) Stock Price

Microbio Co Price

CLOSED
15.30
​
Market closed

Revenue has compounded at 11.7% per year over the past 19 years to 1.89 B TWD. Earnings per share have grown at 6.7% per year over the last 14 years. Microbio Co's net margin stands at -40.0%, down from -13.1% several years earlier. Microbio Co currently offers a dividend yield of about 0.25%.

Microbio Co stock price

Access this data via the Eulerpool API

Microbio Co business model & stock analysis

Microbio Co., Ltd. engages in the research, development, manufacture, and sale of new drugs and healthcare products. The company is headquartered in Taipei City, Taipei. The company went IPO on 2003-02-10. The firm provides fermentation products, including Tien Chun Bao (TCB) oral solutions; herbal products, including LeeHerb series products, as well as organic foods, including vegetables, fruits, nuts, pastry, seasonings, organic meals and others. In addition, it provides new medicines, including anticancer medicines, medicines for hepatitis, allergy, rheumatoid arthritis and others. The firm mainly distributes its products mainly within domestic market.

Frequently asked questions about Microbio Co

Converted at the current exchange rate, the Microbio Co share trades at 0.43 EUR (15.30 TWD).

The revenue cannot currently be calculated for Microbio Co.

The profit cannot currently be calculated for Microbio Co.

The P/E ratio cannot be calculated for Microbio Co at the moment.

The P/S cannot be calculated for Microbio Co currently.

The Eulerpool Quality Score for Microbio Co is 1/10.

The ISIN of Microbio Co is TW0004128004. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Microbio Co is 4128.TWO. The ticker symbol is used to trade Microbio Co shares on the stock exchange.

Fair ValueTerminal
13.46 TWD
Over-/UndervaluationTerminal
Fairly valued
Industry
Personal Care Products
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Taiwan
Currency
TWD
Initial public offering
Feb 10, 2003
ISIN
TW0004128004
Cusip
Y6035R109
Market capitalization
9.00 B TWDMid Cap
52-Week Range
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
1.01
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-8.50 %
Gross Margin
39.78 %
EBIT Margin
-21.47 %
Net Margin
-40.01 %
EPS (Earnings Per Share)
-1.29 TWD
Net Debt / EBIT
—
Debt/Equity
0.06
Dividend
Dividend yield
0.00 %
Payout Ratio
12.75 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
21.00 %
Last updated Oct 5, 2026, 12:55 PM

Microbio Co Peer Group

Microbio Co Ticker

TWO · 4128.TWO

Microbio Co FIGI

4128:TT (Taipei Stock Exchange) · BBG000PN7101

All fundamentals and in-depth analysis of Microbio Co

Our stock analysis for Microbio Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Microbio Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.